Molecular therapy for Cancer: Tumor suppressor MiRNA miR-29c increases the expression of tumor suppressor PTEN via down regulation of its target gene, 29/January/2015, 22.41

Molecular therapy for Cancer: Anti-cancer drug Campothecin (CPT) suppresses the expression of oncogenic Zinc finger protein 217 (ZNF217) via down regulation of its target gene, 29/January/2015, 22.37
January 29, 2015
Natural product-based therapy for p53-mutated human tumors: Agaricus blazei Murill, a medicinal mushroom, promotes the tumor suppressor function of TAp73, increases senescence, and inhibits the expression of cancer stem cell genes via down regulation of its target gene, 29/January/20145, 22.59
January 29, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Molecular therapy for Cancer: Tumor suppressor MiRNA miR-29c increases the expression of tumor suppressor PTEN via down regulation of its target gene, 29/January/2015, 22.41, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: PTEN is the second most mutated gene in human cancer. This study suggests, for the first time, that miR-29c, by suppressing the expression of its target gene, it may increase the expression of PTEN. Thereby, it may promote tumor suppression. Thus, pharmacological formulations encompassing            ” miR-29c  or its activators”  may be used to inhibit the progression of tumors.

Amount: $ 300

Undisclosed information: How miR-29c increases the expression of tumor suppressor PTEN

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.